Cigna Group (NYSE:CI) Receives Average Recommendation of “Moderate Buy” from Analysts

Cigna Group (NYSE:CIGet Free Report) has been assigned an average recommendation of “Moderate Buy” from the twenty-two brokerages that are presently covering the stock, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $339.45.

A number of analysts have commented on the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Robert W. Baird set a $362.00 price objective on Cigna Group in a report on Friday, July 31st. Wolfe Research restated an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and decreased their target price for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Finally, UBS Group upped their target price on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research report on Friday, May 22nd.

Check Out Our Latest Stock Report on Cigna Group

Cigna Group Trading Down 2.7%

NYSE CI opened at $275.03 on Tuesday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a fifty day simple moving average of $285.73 and a two-hundred day simple moving average of $281.32. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $72.67 billion, a P/E ratio of 11.38, a P/E/G ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period in the previous year, the company earned $7.20 earnings per share. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts forecast that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is 25.82%.

Insider Buying and Selling at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Cigna Group

A number of institutional investors have recently modified their holdings of CI. Caitlin John LLC purchased a new stake in shares of Cigna Group in the second quarter worth about $302,000. Equitable Holdings Inc. purchased a new position in Cigna Group during the second quarter valued at approximately $956,000. Centaurus Financial Inc. purchased a new position in Cigna Group during the second quarter valued at approximately $544,000. FSA Advisors Inc. acquired a new position in Cigna Group in the second quarter valued at approximately $297,000. Finally, Jefferies Financial Group Inc. acquired a new position in Cigna Group in the second quarter valued at approximately $1,610,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Analyst Recommendations for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.